Alnylam Pharmaceuticals: Citigroup cuts target price to $250 from $320
ALNY•Citigroup cut its target price for Alnylam Pharmaceuticals to $250 from $320.
Related News
Everus Construction Group target price cut to $139 from $172
ECG•
GFL Environmental rejects takeover proposals, opts to remain public
GFL•
Russian aluminium's share of available LME stocks almost 100% in October
XLB•
Ambiq Q3 2026 gross profit more than doubles
AMBQ•
Venture Global gains on forecast raise, core profit beat
VG•